• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.52% Nasdaq Down 0.25%

    OXiGENE, Inc. (OXGN)

    -NasdaqCM
    1.35 Down 0.03(2.17%) Aug 3, 3:59PM EDT
    Add to Portfolio
    Prev Close:1.38
    Open:1.37
    Bid:0.10 x 200
    Ask:1.42 x 200
    1y Target Est:6.50
    Beta:0.93
    Next Earnings Date: 4-Aug-15OXGN Earnings announcement
    Day's Range:1.33 - 1.39
    52wk Range:1.27 - 2.53
    Volume:149,193
    Avg Vol (3m):388,202
    Market Cap:35.84M
    P/E (ttm):N/A
    EPS (ttm):-0.64
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OXGN

    Comparison

    Symbol% ChgMkt Cap
    OXGNDown 2.17%35.84M
    AZNUp 0.44%42.90B
    SNYDown 0.94%139.85B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.60
    Quarterly EPS Est (Jun-15) :-0.10
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OXiGENE, Inc., a biopharmaceutical company, focuses on the development of vascular disrupting agents to treat cancer in the United States. Its principal clinical stage product includes fosbretabulin tromethamine, a reversible tubulin binding agent... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback